Number of Intermediate- and High-Risk Factors Significantly Predicts Biochemical Survival and Prostate Cancer-Specific Survival After Low-Dose-Rate Brachytherapy

被引：0
|
作者：
Shasha, D. [1 ]
Salant, R. [1 ]
Sivathayalan, A. [2 ]
Farrell, P. J. [2 ]
Mourad, W. F. [1 ]
Harrison, L. B. [1 ]
机构：
[1] Mt Sinai Beth Israel Med Ctr, New York, NY USA
[2] Carleton Univ, Ottawa, ON K1S 5B6, Canada
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2015年 / 93卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2015.07.1172
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2617
引用
收藏
页码：E248 / E249
页数：2
相关论文
共 50 条
  • [31] THE NUMBER OF POSITIVE SECTION MARGINS IN HIGH-RISK PROSTATE CANCER IS A POWERFUL AND INDEPENDENT PREDICTOR OF CANCER-SPECIFIC AND OVERALL SURVIVAL IN HIGH-RISK LOCALIZED PROSTATE CANCER
    Joniau, S.
    Gontero, P.
    Briganti, A.
    Marchioro, G.
    Capitanio, U.
    Tombal, B.
    Hsu, C. Y.
    Akdogan, B.
    Bader, P.
    Frea, B.
    Frohneberg, D.
    Kneitz, B.
    Riedmiller, H.
    Tizzani, A.
    Van Poppel, H.
    Spahn, M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 285 - 285
  • [32] Distinguishing prostate-specific antigen bounces from biochemical failure after low-dose-rate prostate brachytherapy
    Hackett, Cian
    Ghosh, Sunita
    Sloboda, Ron
    Martell, Kevin
    Lan, Lanna
    Pervez, Nadeem
    Pedersen, John
    Yee, Don
    Murtha, Albert
    Amanie, John
    Usmani, Nawaid
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2014, 6 (03) : 247 - 253
  • [33] High intermediate prostate cancer treated with low-dose-rate brachytherapy with or without androgen deprivation therapy
    Pickles, Tom
    Morris, W. James
    Keyes, Mira
    BRACHYTHERAPY, 2017, 16 (06) : 1101 - 1105
  • [34] Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors
    Martinez, A
    Gonzalez, J
    Spencer, W
    Gustafson, G
    Kestin, L
    Kearney, D
    Vicini, FA
    JOURNAL OF UROLOGY, 2003, 169 (03): : 974 - 979
  • [35] Differences in overall survival and cancer-specific survival in high-risk prostate cancer patients according to the primary treatment
    Cano-Velasco, J.
    Herranz-Amo, F.
    Barbas-Bernardos, G.
    Polanco-Pujol, L.
    Hernandez-Cavieres, J.
    Lledo-Garcia, E.
    Hernandez-Fernandez, C.
    ACTAS UROLOGICAS ESPANOLAS, 2019, 43 (02): : 91 - 98
  • [36] Effect of Positive Biopsy Core Rate on Low-dose-rate Brachytherapy Outcomes in Intermediate-risk Prostate Cancer
    Kusuhara, Yoshito
    Fukawa, Tomoya
    Fukumori, Tomoharu
    Ueno, Yoshiteru
    Daizumoto, Kei
    Sasaki, Yutaro
    Tomida, Ryotaro
    Yamamoto, Yasuyo
    Yamaguchi, Kunihisa
    Tonoiso, Chisato
    Kubo, Akiko
    Kawanaka, Takashi
    Furutani, Shunsuke
    Ikushima, Hitoshi
    Kanayama, Hiro-omi
    Takahashi, Masayuki
    ANTICANCER RESEARCH, 2023, 43 (10) : 4627 - 4635
  • [37] Urinary Retention and Incontinence after Low-Dose-Rate Brachytherapy for Prostate Cancer
    Leapman M.S.
    Stone N.N.
    Current Bladder Dysfunction Reports, 2013, 8 (3) : 236 - 241
  • [38] Pulmonary Metastases After Low-Dose-Rate Brachytherapy for Localized Prostate Cancer
    Kido, Masahito
    Kuruma, Hidetoshi
    Sasaki, Hiroshi
    Miki, Kenta
    Aoki, Manabu
    Kimura, Takahiro
    Takahash, Hiroyuki
    Kanehira, Chihiro
    Egawa, Shin
    KOREAN JOURNAL OF UROLOGY, 2014, 55 (05) : 309 - 314
  • [39] OVERALL AND CANCER-SPECIFIC SURVIVAL OF HIGH-RISK PROSTATE CANCER - IMPACT OF ADJUVANT THERAPY AFTER RADICAL PROSTATECTOMY
    Ganev, Tosho
    JOURNAL OF IMAB, 2023, 29 (04): : 5188 - 5191
  • [40] Direct Comparison of Two Different Definitions with Biochemical Recurrence after Low-Dose-Rate Brachytherapy for Prostate Cancer
    Takeuchi, Shinichi
    Iinuma, Koji
    Nakane, Keita
    Nakano, Masahiro
    Kawase, Makoto
    Kawase, Kota
    Takai, Manabu
    Kato, Daiki
    Mori, Takayuki
    Takano, Hirota
    Kumano, Tomoyasu
    Matsuo, Masayuki
    Koie, Takuya
    CURRENT ONCOLOGY, 2023, 30 (03) : 2792 - 2800
12345